Diffuse malignant mesothelioma of the peritoneum and pleura, analysis of markers. - Wikidata - wikimedia - TriplyDB

Diffuse malignant mesothelioma of the peritoneum and pleura, analysis of markers.

Diffuse malignant mesothelioma of the peritoneum and pleura, analysis of markers.

http://www.wikidata.org/entity/Q44771914

about

BAP1 mutation is a frequent somatic event in peritoneal malignant mesothelioma.Whole exome sequencing of an asbestos-induced wild-type murine model of malignant mesothelioma.Clinical implications of novel activating EGFR mutations in malignant peritoneal mesothelioma.Experience with peritoneal mesothelioma at the Milan National Cancer Institute.Telomerase activity in pleural malignant mesotheliomas.A Histomorphologic Grading System That Predicts Overall Survival in Diffuse Malignant Peritoneal Mesothelioma With Epithelioid Subtype Reduction of estradiol in human malignant pleural mesothelioma tissues may prevent tumour growth, as implied by in in-vivo and in-vitro models Intraperitoneal chemotherapy for peritoneal surface malignancy: experience with 1,000 patients.Exemestane blocks mesothelioma growth through downregulation of cAMP, pCREB and CD44 implicating new treatment option in patients affected by this disease Diffuse malignant peritoneal mesothelioma: systematic review of clinical management and biological research.The prognostic significance of BAP1, NF2, and CDKN2A in malignant peritoneal mesothelioma.MR imaging features of peritoneal adenomatoid mesothelioma: a case report.Novel and existing mutations in the tyrosine kinase domain of the epidermal growth factor receptor are predictors of optimal resectability in malignant peritoneal mesothelioma.A comparison of epidermal growth factor receptor expression in malignant peritoneal and pleural mesothelioma.Epidermal growth factor receptor overexpression in malignant pleural mesothelioma: prognostic correlations.Association Between Clinicopathological Factors and Genomic Abnormalities Detected by FISH Analysis in Epithelioid Diffuse Malignant Pleural Mesothelioma.Evaluation of New Biomarkers in the Prediction of Malignant Mesothelioma in Subjects with Environmental Asbestos Exposure.Cytologic examination of ascitic fluid in a patient with pleural-based mass: A unique presentation of a rare tumor

P2860

Q30412528-55DBA569-7812-44B7-9A97-43AFE002E766 Q33755896-87FC8EA1-CFE6-47ED-A614-0853C412BD52 Q34267563-598FF995-44F5-47FA-82CF-5B11316145A3 Q34391082-15824669-253E-42BC-9818-9E401D46B29E Q35103570-E4839445-65D5-45AB-ADBE-2E261D1221DB Q37268597-D2E002ED-FCE3-481B-BB32-462091160C60 Q37565062-EBC04D63-C3E8-4D4E-BA0E-38D61CF7B736 Q37662806-1B92D274-8A90-4052-852D-D71DA00E04D4 Q37686318-4A220C82-4BA0-477E-935D-4CA92DE59546 Q37833952-A54841B8-0641-461D-BAAC-3E64A8BE7607 Q38950690-B56980E8-0529-4C24-873D-E33CE24C48E9 Q43148595-22B0E2DF-9070-4F19-952F-C73483163A50 Q46255077-EE8F5970-9B79-4FBA-8B13-3988C14DC10E Q54521295-00FACE9D-131F-46D6-89FE-ED7F0BD7E0E2 Q54601144-8EC46447-B43C-458C-A119-874B42CFC782 Q54779306-69CB8D06-87FE-48F8-9701-D49FA081541D Q55026044-3663DBD2-CF38-462C-96F7-56705E74AA24 Q58561912-76E06F59-CC48-4C62-A99B-6B4ECDCF4A3A

P2860

Diffuse malignant mesothelioma of the peritoneum and pleura, analysis of markers.

http://www.wikidata.org/entity/Q44771914

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh-hant

name

Diffuse malignant mesothelioma of the peritoneum and pleura, analysis of markers.

@en

Diffuse malignant mesothelioma of the peritoneum and pleura, analysis of markers.

@nl

type

label

Diffuse malignant mesothelioma of the peritoneum and pleura, analysis of markers.

@en

Diffuse malignant mesothelioma of the peritoneum and pleura, analysis of markers.

@nl

prefLabel

Diffuse malignant mesothelioma of the peritoneum and pleura, analysis of markers.

@en

Diffuse malignant mesothelioma of the peritoneum and pleura, analysis of markers.

@nl

P1433

Q44771914-52F0706E-A1F9-4B6C-AF6F-63C1EDE3B7B6

P1476

Q44771914-7C4FF15E-B4C9-484A-A8F3-1867A4C405C0

P2093

Q44771914-43918CD6-D1B7-4F7A-9A36-398D4B01280E

Q44771914-53B76D65-48E2-46C7-ACB0-A362B958DF2D

Q44771914-7AA5BBA7-3AB3-46DF-8D15-9903A734DB5E

Q44771914-7DB02CF1-48ED-46F9-84CD-386A7A4C587D

Q44771914-B63084BD-6B02-4C4F-84F8-C068FC0DA4CB

Q44771914-DD3099D5-02F9-4901-8CF3-200A7F895790

Q44771914-DD9057C9-20B2-4D6C-A475-E0D82DF5F17D

P2860

Q44771914-08D38E78-6DD1-4A21-9EFE-64F41AA16321

Q44771914-216174E7-38A8-48D6-80D1-3E6D1242EFFC

Q44771914-5BF476A8-604E-48D9-BA6A-54BBDA5334D5

Q44771914-5F4E3B6D-E636-4D0B-A17C-A0ED931CA04F

Q44771914-652AA964-4AED-4C03-82BC-24D42B7547D1

Q44771914-928A4CCD-F564-416F-85BF-55385D0CD4DF

Q44771914-AD267581-BFC5-4988-9B6C-50042ED66B5E

Q44771914-BE56D262-D18C-40AC-ADA7-438DBE5D4A71

Q44771914-C414A3EE-56E4-461B-B90A-5A087BB0B3F3

Q44771914-C9DCDD95-1B5A-4A68-93A9-A12B82AD1157

P2888

Q44771914-F234A4BD-EF25-480B-B218-2BA5447AAF14

P304

Q44771914-B8F43B82-5D38-4AE4-983C-C2B0CCD0A093

P31

Q44771914-F99DE802-4EA2-47BC-929D-76CE2ECBF9C7

P356

Q44771914-9D0A0482-22A0-4C4F-A737-897D95885EA7

P433

Q44771914-B937A522-F435-406F-814D-E42062F33267

P478

Q44771914-F50D21E1-DC79-412E-9648-217EB2252C0E

P577

Q44771914-4BAA4223-3DFE-4A7A-B299-07725CA98EE8

P5875

Q44771914-FDFE17D3-D2B7-4264-BDA6-EA8E70D399A1

P698

Q44771914-54E39E11-3599-4EDB-8944-188DD982F25A

P356

MODPATHOL.3800067

P1433

Modern Pathology

P1476

Diffuse malignant mesothelioma of the peritoneum and pleura, analysis of markers.

@en

P2093

Doug Case

http://www.w3.org/2001/XMLSchema#string

Edward A Levine

http://www.w3.org/2001/XMLSchema#string

Jacqueline K Trupiano

http://www.w3.org/2001/XMLSchema#string

Kim R Geisinger

http://www.w3.org/2001/XMLSchema#string

Mark C Willingham

http://www.w3.org/2001/XMLSchema#string

Nora Zbieranski

http://www.w3.org/2001/XMLSchema#string

Paul Manders

http://www.w3.org/2001/XMLSchema#string

P2860

Long-term apoptotic cell death process with increased expression and activation of caspase-3 and -6 in adult rat germ cells exposed in utero to flutamide

Value of mesothelial and epithelial antibodies in distinguishing diffuse peritoneal mesothelioma in females from serous papillary carcinoma of the ovary and peritoneum.

The immunohistochemical diagnosis of epithelial mesothelioma.

New approaches for mesothelioma: biologics, vaccines, gene therapy, and other novel agents.

Multicenter randomized controlled trial of the management of unresectable malignant mesothelioma proposed by the British Thoracic Society and the British Medical Research Council.

Peritoneal mesothelioma.

Surgical treatment of malignant pleural mesothelioma: a review.

Malignant pleural mesothelioma and epidermal growth factor receptor (EGF-R). Relationship of EGF-R with histology and survival using fixed paraffin embedded tissue and the F4, monoclonal antibody.

Primary malignant peritoneal mesothelioma. A report of seven cases and a review of the literature.

c-Kit is not expressed in malignant mesothelioma.

P2888

modpathol.3800067

P304

476-481

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/MODPATHOL.3800067

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P577

2004-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

232775479

http://www.w3.org/2001/XMLSchema#string

P698

14976533

http://www.w3.org/2001/XMLSchema#string